Publikationen, an denen er mitarbeitet Jaime Kulisevsky (2)

2022

  1. Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

    Parkinsonism and Related Disorders, Vol. 96, pp. 65-73

2021

  1. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1